Vincerx Pharma Inc (VINC)
US Market

Vincerx Pharma Inc Stock Analysis & Ratings

VINC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.26 - $18.43
Previous Close$1.4
Average Volume (3M)147.61K
Market CapN/A
Enterprise ValueN/A
P/E Ratio-0.5
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart ScoreN/A



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vincerx Pharma Inc’s price range in the past 12 months?
Vincerx Pharma Inc lowest stock price was $1.26 and its highest was $18.43 in the past 12 months.
    What is Vincerx Pharma Inc’s market cap?
    Currently, no data Available
    What is Vincerx Pharma Inc’s price target?
    The average price target for Vincerx Pharma Inc is $6.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $8.00 ,the lowest forecast is $4.00. The average price target represents 328.57% Increase from the current price of $1.4.
      What do analysts say about Vincerx Pharma Inc?
      Vincerx Pharma Inc’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
        When is Vincerx Pharma Inc’s upcoming earnings report date?
        Vincerx Pharma Inc’s upcoming earnings report date is Aug 11, 2022 which is in 40 days.
          How were Vincerx Pharma Inc’s earnings last quarter?
          Vincerx Pharma Inc released its earnings results on May 12, 2022. The company reported -$0.79 earnings per share for the quarter, missing the consensus estimate of -$0.756 by -$0.034.
            Is Vincerx Pharma Inc overvalued?
            According to Wall Street analysts Vincerx Pharma Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Vincerx Pharma Inc pay dividends?
              Vincerx Pharma Inc does not currently pay dividends.
              What is Vincerx Pharma Inc’s EPS estimate?
              Vincerx Pharma Inc’s EPS estimate is -$0.8.
                How many shares outstanding does Vincerx Pharma Inc have?
                Vincerx Pharma Inc has 21,057,560 shares outstanding.
                  What happened to Vincerx Pharma Inc’s price movement after its last earnings report?
                  Vincerx Pharma Inc reported an EPS of -$0.79 in its last earnings report, missing expectations of -$0.756. Following the earnings report the stock price went down -6.114%.
                    Which hedge fund is a major shareholder of Vincerx Pharma Inc?
                    Among the largest hedge funds holding Vincerx Pharma Inc’s share is Deerfield Management Company, LP. It holds Vincerx Pharma Inc’s shares valued at 6M.


                      Vincerx Pharma Inc Stock Analysis

                      Smart Score
                      Not Ranked
                      Price Target
                      ▲(328.57% Upside)
                      Strong Buy
                      This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Vincerx Pharma Inc

                      LifeSci Acquisition Corp is a blank check company.

                      Similar Stocks
                      Price & Change
                      Nuvve Holding
                      Greenrose Acquisition
                      UWM Holding

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis